thread-index: AdzzezUK9iixUaDUTSG5ymzRmebJXQ== Thread-Topic: Mehran Karimi, MD From: "http://gsia.sums.ac.ir/" Subject: Mehran Karimi, MD Organization: Targan Management Systems, http://www.targan.ir MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_0032_01DCF340.88BA00A0" Content-Location: https://gsia.sums.ac.ir/en/ps/menu/18716 Content-Class: urn:content-classes:message Importance: normal Priority: normal X-MimeOLE: Produced By Microsoft MimeOLE This is a multi-part message in MIME format. ------=_NextPart_000_0032_01DCF340.88BA00A0 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 7bit Shiraz University of Medical Sciences - SUMS Code : 18716 Publish Date : Monday, July 6, 2020 Visit : 4144 Mehran Karimi, MD Mehran Karimi, MD Mehran Karimi, MD Professor of Pediatric Hematology and Oncology Hematology Research Center Shiraz University of Medical Sciences E-mail: mkarimi820@gmail.com Biography Mehran Karimi is a Professor of Pediatric Hematology-Oncology, School of Medicine, Shiraz University of Medical Sciences (SUMS). Moreover, he was the director of SUMS Hematology Research Center for at least 10 years. He has actively worked for the last 25 years at SUMS in the fields of thalassemia, hemophilia, homeostasis, and thrombosis. After graduating in Doctor of Medicine (MD) from SUMS, he did his subspecialty in hematology at SUMS and Ahvaz Jondishahpour University of Medical Sciences while his focus was on thalassemia and hemophilia. He also completed two separate six-month fellowships in Leeds, the UK in 1996 and Milan, Italy in 2001 & 2003. His main research interests are in thalassemia, hemophilia, rare bleeding disorders, sickle cell and thrombophilia, and currently is the head of programs at the hospital referral in Shiraz in those disease zones. Dr. Karimi is a member of ISTH, ASH, and the Iranian Pediatric Hematology-Oncology Society as well as a reviewer of some peer-reviewed journals. He was selected as the best researcher and also was given two awards by Razi Festival in 2003 and 2008 and the 15th Abu Reyhan Biruni Research Festival in 2014. He was selected as the best researcher at SUMS from 2004 to 2014. He received two appreciation letters from ISTH (International Society Thrombosis and Hemostasis) and TIF (Thalassemia International Federation) due to significant scientific works, having international congress as president and international speakers in these fields. Dr. Mehran Karimi has authored 350 publications until July 2020 and more than 300 abstracts in peer-reviewed journals and international meetings. He has been an honorary keynote speaker at several national and international conferences, congresses and seminars. Significant International Collaborations Total number of publications: 350 Number of joint publications: More than100 International affiliation: 14249 Carlow Run, Carmel IN 46074, USA International Research Projects and Grants Year Project title Funding 2015-2018 Forma02, 04 study (Mutinational study, clinical response of a new plasma drived Fibrinogen concentrate in Afibrinogenemia patitients). Local principal investigator $50000 grant 2010-2014 SIPPET Study (Comparing incidence of Inhibitor development in untreated Hemophilia A patients bewwen plasma drived and recombinant). Local principle investigator $220000 grant 2012-2018 Winter Study (Von willbrand disease registry & inhibitor development, A 5-year International Registries and Prospective Study on VWD Type 3), Local principal investigator $10000 grant 2012-2014 Forma-1 Study (Multinational study of PK assay of a new Fibrinogen concentrate in Afibrinogenemia patients). Local principal investigator $27000 grant 2012-2015 Smart Study (Immunogenicity evaluation of RT rFVIIa in hemophilia A patients with high titer inhibitor). Principal investigator $10000 grant 2006-2007 STER Study (Factor VII registery in patients with congenital FVII deficiency). Principle investigator $12000 grant 2009-2010 FX Study (Clinical and PK evaluation of a new FX concentrate in congenital FX deficiency). Principal investigator $20000 grant 2009-2010 Optimal care study (Clinical and paraclinical evaluation of Thalassemia intermediate Patients), Local principalinvestigator $7500 grant ------=_NextPart_000_0032_01DCF340.88BA00A0 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: 8bit Shiraz University of Medical Sciences - SUMS
Shiraz University of Medical Sciences - SUMS
Code : 18716      Publish Date : Monday, July 6, 2020 Visit : 4144

Mehran Karimi, MD

Mehran Karimi, MD

 

 

Mehran Karimi, MD

Professor of Pediatric Hematology and Oncology

Hematology Research Center

Shiraz University of Medical Sciences

E-mail:  mkarimi820@gmail.com
   

 

 

 

 

 

 

 

 

 

 


 

Biography

Mehran Karimi is a Professor of Pediatric Hematology-Oncology, School of Medicine, Shiraz University of Medical Sciences (SUMS). Moreover, he was the director of SUMS Hematology Research Center for at least 10 years. He has actively worked for the last 25 years at SUMS in the fields of thalassemia, hemophilia, homeostasis, and thrombosis. After graduating in Doctor of Medicine (MD) from SUMS, he did his subspecialty in hematology at SUMS and Ahvaz Jondishahpour University of Medical Sciences while his focus was on thalassemia and hemophilia. He also completed two separate six-month fellowships in Leeds, the UK in 1996 and Milan, Italy in 2001 & 2003. His main research interests are in thalassemia, hemophilia, rare bleeding disorders, sickle cell and thrombophilia, and currently is the head of programs at the hospital referral in Shiraz in those disease zones.

Dr. Karimi is a member of ISTH, ASH, and the Iranian Pediatric Hematology-Oncology Society as well as a reviewer of some peer-reviewed journals. He was selected as the best researcher and also was given two awards by Razi Festival in 2003 and 2008 and the 15th Abu Reyhan Biruni Research Festival in 2014. He was selected as the best researcher at SUMS from 2004 to 2014. He received two appreciation letters from ISTH (International Society Thrombosis and Hemostasis) and TIF (Thalassemia International Federation) due to significant scientific works, having international congress as president and international speakers in these fields. Dr. Mehran Karimi has authored 350 publications until July 2020 and more than 300 abstracts in peer-reviewed journals and international meetings. He has been an honorary keynote speaker at several national and international conferences, congresses and seminars.

 

Significant International Collaborations

Total number of publications: 350

Number of joint publications: More than100

International affiliation: 14249 Carlow Run, Carmel IN 46074, USA

 

 

International Research Projects and Grants

 

Year

Project title

Funding

2015-2018  

Forma02, 04 study (Mutinational study, clinical response of a new plasma drived Fibrinogen concentrate in Afibrinogenemia patitients). Local principal investigator

$50000 grant

2010-2014

SIPPET Study (Comparing incidence of Inhibitor development in untreated Hemophilia A patients bewwen plasma drived and recombinant). Local principle investigator

$220000 grant

2012-2018

Winter Study (Von willbrand disease registry & inhibitor development, A 5-year International Registries and Prospective Study on VWD Type 3), Local principal investigator

$10000 grant

2012-2014 

Forma-1 Study (Multinational study of PK assay of a new Fibrinogen concentrate in Afibrinogenemia patients). Local principal investigator

$27000 grant

2012-2015

Smart Study (Immunogenicity evaluation of RT rFVIIa in hemophilia A patients with high titer inhibitor). Principal investigator

$10000 grant

2006-2007

STER Study (Factor VII registery in patients with congenital FVII deficiency). Principle investigator

 

$12000 grant

2009-2010

FX Study (Clinical and PK evaluation of a new FX concentrate in congenital FX deficiency). Principal investigator

 

$20000 grant

2009-2010

Optimal care study (Clinical and paraclinical evaluation of Thalassemia intermediate Patients), Local principalinvestigator

 

$7500 grant

 

 


------=_NextPart_000_0032_01DCF340.88BA00A0--